Abbott is a world leader in rapid diagnostics at the point of care, with a focus on cardio metabolic disease, infectious disease and toxicology.
Through our mission, we aim to improve clinical outcomes, reduce healthcare costs and deliver earnings growth to our investors.
Each territory in Africa is assigned to a specific Alere Business Manager who will have the responsibility to support you for all the essential commercial activities
We are a global leader in the field of rapid diagnostic tests designed to improve the quality of patient care. Specific product lines include tests for rapid and early diagnosis in the fields of cardiovascular, infectious diseases, women's health, drugs of abuse and oncology.
Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Discover a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.
Abbott products give providers, physicians and patients access to the right information at the right time.
Our products and services include tests to assist in the diagnosis and management of many cardiometabolic factors and conditions.
Our products and services include tests to assist in the diagnosis and management of many infectious diseases.
Broad drug and alcohol testing portfolio includes rapid analyzer-based tests, visual-read screening devices, laboratory tests, and immunoassay reagents.
Alere™ Toxicology offers drug testing products and services that are used in a multitude of settings such as hospitals, clinics, physician offices, criminal justice, workplace, rehabilitation, occupational health clinics, and home testing.
Our innovative diagnostics provide reliable and actionable information that enables informed decision-making by healthcare professionals at the point-of-care.
Our rapid diagnostic products are changing how healthcare is delivered-extending diagnosis and health management from the lab, doctor's office and hospital into people's homes.
Connect with us.
Contact us for sales assistance, technical support or further information.
The Clinical Laboratory Improvement Amendments (CLIA) program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing. We are pleased to provide you with materials to support your IQCPs.
Explore opportunities to achieve the extraordinary in your career. Get started today by searching job openings and submitting your resume for consideration.
Please select your country.
8 Product Demos
4 Product Demos
5 Product Demos
How to Use Product Demo
2 Product Demos
Alere Actim PROM Demo
Alere Actim Partus Demo
3 Product Demos
Sign up to receive valuable updates from Abbott.
Explore more with Abbott
Here are the
Based on your current location, the content on this page may not be relevant for your country.Please click here to return to the homepage. Alternatively, click the X button to acknowledge and proceed.Close